Clinical Trial Update: The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study [NA]

View source ↗

Summary

This completed pilot trial evaluated the gastrointestinal microbiome in infants with gastroesophageal reflux disease who received proton pump inhibitor therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: Medical University of Graz | Conditions: Gastroesophageal Reflux | NA | Status: COMPLETED